Nov 5
Earnings call
Revenue rises 18.6%; margin recovery targeted
Kansai Neuralac reported consolidated quarterly net revenue growth of 18.6%, PBDIT growth of 4.1% and PBT growth of 3.6%. Management targets a sustainable 13 to 14% EBITDA margin by quarter four while seeking further price increases.